| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biochemistry |
Wellcome/CRC Institute, Cambridge, CB2 1QR; and Department of Zoology, University of Cambridge, Cambridge, CB2 3EJ, United Kingdom
The DNA-dependent protein kinase (DNA-PK) is a serine/threonine protein kinase that is involved in mammalian DNA double-strand break repair. The catalytic subunit of DNA-PK (DNA-PKcs) shares sequence homology in its kinase domain with phosphatidylinositol (PI) 3-kinase. Here, we provide a detailed kinetic analysis of DNA-PK inhibition by the PI 3-kinase inhibitor wortmannin and demonstrate this inhibition to be of a noncompetitive nature, with a Ki of 120 nM. Another inhibitor of PI 3-kinase, LY294002, its parent compound, quercetin, and other derivatives have also been studied. These chemicals are competitive inhibitors of DNA-PK, with LY294002 having a Ki of 6.0 µM. Using an antibody to wortmannin, we found that this compound binds covalently to the kinase domain of DNA-PKcs both in vitro and in vivo. Binding of wortmannin to the active site of DNA-PKcs is inhibited by ATP but not by a peptide substrate. Furthermore, wortmannin is able to bind to DNA-PKcs independently of Ku, and it is not stimulated by the presence of DNA. This suggests that the ATP binding site of DNA-PKcs is open constitutively and that DNA activation of the kinase is mediated via another mechanism.
This article has been cited by other articles:
![]() |
R. Prevo, E. Deutsch, O. Sampson, J. Diplexcito, K. Cengel, J. Harper, P. O'Neill, W. G. McKenna, S. Patel, and E. J. Bernhard Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity Cancer Res., July 15, 2008; 68(14): 5915 - 5923. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Willmore, S. L. Elliott, T. Mainou-Fowler, G. P. Summerfield, G. H. Jackson, F. O'Neill, C. Lowe, A. Carter, R. Harris, A. R. Pettitt, et al. DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia Clin. Cancer Res., June 15, 2008; 14(12): 3984 - 3992. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Kao, Z. Jiang, A. M. Fernandes, A. K. Gupta, and A. Maity Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing Radiation J. Biol. Chem., July 20, 2007; 282(29): 21206 - 21212. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Jiang, N. Pore, G. J. Cerniglia, R. Mick, M.-M. Georgescu, E. J. Bernhard, S. M. Hahn, A. K. Gupta, and A. Maity Phosphatase and Tensin Homologue Deficiency in Glioblastoma Confers Resistance to Radiation and Temozolomide that Is Reversed by the Protease Inhibitor Nelfinavir Cancer Res., May 1, 2007; 67(9): 4467 - 4473. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Geng, X. Zhang, S. Zheng, and R. J. Legerski Artemis Links ATM to G2/M Checkpoint Recovery via Regulation of Cdk1-Cyclin B Mol. Cell. Biol., April 1, 2007; 27(7): 2625 - 2635. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Al-Alwan, K. Okkenhaug, B. Vanhaesebroeck, J. S. Hayflick, and A. J. Marshall Requirement for Phosphoinositide 3-Kinase p110{delta} Signaling in B Cell Antigen Receptor-Mediated Antigen Presentation J. Immunol., February 15, 2007; 178(4): 2328 - 2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. de la Pena, W. E. Burgan, D. J. Carter, M. G. Hollingshead, M. Satyamitra, K. Camphausen, and P. J. Tofilon Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells. Mol. Cancer Ther., June 1, 2006; 5(6): 1504 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, H. D. Thomas, M. A. Batey, I. G. Cowell, C. J. Richardson, R. J. Griffin, A. H. Calvert, D. R. Newell, G. C.M. Smith, and N. J. Curtin Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441. Cancer Res., May 15, 2006; 66(10): 5354 - 5362. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sakasai, K. Shinohe, Y. Ichijima, N. Okita, A. Shibata, K. Asahina, and H. Teraoka Differential involvement of phosphatidylinositol 3-kinase-related protein kinases in hyperphosphorylation of replication protein A2 in response to replication-mediated DNA double-strand breaks Genes Cells, March 1, 2006; 11(3): 237 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Frasca, E. Van der Put, A. M. Landin, D. Gong, R. L. Riley, and B. B. Blomberg RNA Stability of the E2A-Encoded Transcription Factor E47 Is Lower in Splenic Activated B Cells from Aged Mice J. Immunol., November 15, 2005; 175(10): 6633 - 6644. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Parsons Phosphatidylinositol 3-Kinase Inhibitors Are a Triple Threat to Ovarian Cancer Clin. Cancer Res., November 15, 2005; 11(22): 7965 - 7966. [Full Text] [PDF] |
||||
![]() |
M. Yaneva, H. Li, T. Marple, and P. Hasty Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor Nucleic Acids Res., September 21, 2005; 33(16): 5320 - 5330. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Santiago-Walker, A. J. Fikaris, G. D. Kao, E. J. Brown, M. G. Kazanietz, and J. L. Meinkoth Protein Kinase C {delta} Stimulates Apoptosis by Initiating G1 Phase Cell Cycle Progression and S Phase Arrest J. Biol. Chem., September 16, 2005; 280(37): 32107 - 32114. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Poh and S. Pervaiz LY294002 and LY303511 Sensitize Tumor Cells to Drug-Induced Apoptosis via Intracellular Hydrogen Peroxide Production Independent of the Phosphoinositide 3-Kinase-Akt Pathway Cancer Res., July 15, 2005; 65(14): 6264 - 6274. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Erker, R. Schubert, H. Yakushiji, C. Barlow, D. Larson, J. B. Mitchell, and A. Wynshaw-Boris Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor Hum. Mol. Genet., June 15, 2005; 14(12): 1699 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Deriano, O. Guipaud, H. Merle-Beral, J.-L. Binet, M. Ricoul, G. Potocki-Veronese, V. Favaudon, Z. Maciorowski, C. Muller, B. Salles, et al. Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway Blood, June 15, 2005; 105(12): 4776 - 4783. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Bladen, D. Udayakumar, Y. Takeda, and W. S. Dynan Identification of the Polypyrimidine Tract Binding Protein-associated Splicing Factor{middle dot}p54(nrb) Complex as a Candidate DNA Double-strand Break Rejoining Factor J. Biol. Chem., February 18, 2005; 280(7): 5205 - 5210. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kysela, M. Chovanec, and P. A. Jeggo Phosphorylation of linker histones by DNA-dependent protein kinase is required for DNA ligase IV-dependent ligation in the presence of histone H1 PNAS, February 8, 2005; 102(6): 1877 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hickson, Y. Zhao, C. J. Richardson, S. J. Green, N. M. B. Martin, A. I. Orr, P. M. Reaper, S. P. Jackson, N. J. Curtin, and G. C. M. Smith Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM Cancer Res., December 15, 2004; 64(24): 9152 - 9159. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, J. Succi, Z. Feng, S. Prithivirajsingh, M. D. Story, and R. J. Legerski Artemis Is a Phosphorylation Target of ATM and ATR and Is Involved in the G2/M DNA Damage Checkpoint Response Mol. Cell. Biol., October 15, 2004; 24(20): 9207 - 9220. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Block, Y. Yu, D. Merkle, J. L. Gifford, Q. Ding, K. Meek, and S. P. Lees-Miller Autophosphorylation-dependent remodeling of the DNA-dependent protein kinase catalytic subunit regulates ligation of DNA ends Nucleic Acids Res., August 16, 2004; 32(14): 4351 - 4357. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Solomon, M. C. Cardoso, and E. S. Knudsen Dynamic targeting of the replication machinery to sites of DNA damage J. Cell Biol., August 16, 2004; 166(4): 455 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Willmore, S. de Caux, N. J. Sunter, M. J. Tilby, G. H. Jackson, C. A. Austin, and B. W. Durkacz A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia Blood, June 15, 2004; 103(12): 4659 - 4665. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tanno, N. Yanagawa, A. Habiro, K. Koizumi, Y. Nakano, M. Osanai, Y. Mizukami, T. Okumura, J. R. Testa, and Y. Kohgo Serine/Threonine Kinase AKT Is Frequently Activated in Human Bile Duct Cancer and Is Associated with Increased Radioresistance Cancer Res., May 15, 2004; 64(10): 3486 - 3490. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Block, D. Merkle, K. Meek, and S. P. Lees-Miller Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine Nucleic Acids Res., April 1, 2004; 32(6): 1967 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stiff, M. O'Driscoll, N. Rief, K. Iwabuchi, M. Lobrich, and P. A. Jeggo ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation Cancer Res., April 1, 2004; 64(7): 2390 - 2396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kashishian, H. Douangpanya, D. Clark, S. T. Schlachter, C. T. Eary, J. G. Schiro, H. Huang, L. E. Burgess, E. A. Kesicki, and J. Halbrook DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer Mol. Cancer Ther., December 1, 2003; 2(12): 1257 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, Y. Takeda, S. Wragg, J. Barrett, A. Phillips, and W. S. Dynan Modification of the ionizing radiation response in living cells by an scFv against the DNA-dependent protein kinase Nucleic Acids Res., October 15, 2003; 31(20): 5848 - 5857. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Durant and P. Karran Vanillins--a novel family of DNA-PK inhibitors Nucleic Acids Res., October 1, 2003; 31(19): 5501 - 5512. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Veuger, N. J. Curtin, C. J. Richardson, G. C. M. Smith, and B. W. Durkacz Radiosensitization and DNA Repair Inhibition by the Combined Use of Novel Inhibitors of DNA-dependent Protein Kinase and Poly(ADP-Ribose) Polymerase-1 Cancer Res., September 15, 2003; 63(18): 6008 - 6015. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sak, M. Stuschke, R. Wurm, G. Schroeder, B. Sinn, G. Wolf, and V. Budach Selective Inactivation of DNA-dependent Protein Kinase with Antisense Oligodeoxynucleotides: Consequences for the Rejoining of Radiation-induced DNA Double-Strand Breaks and Radiosensitivity of Human Cancer Cell Lines Cancer Res., November 15, 2002; 62(22): 6621 - 6624. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Krystal, G. Sulanke, and J. Litz Inhibition of Phosphatidylinositol 3-Kinase-Akt Signaling Blocks Growth, Promotes Apoptosis, and Enhances Sensitivity of Small Cell Lung Cancer Cells to Chemotherapy Mol. Cancer Ther., September 1, 2002; 1(11): 913 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Edwards, L. Geng, J. Tan, H. Onishko, E. Donnelly, and D. E. Hallahan Phosphatidylinositol 3-Kinase/Akt Signaling in the Response of Vascular Endothelium to Ionizing Radiation Cancer Res., August 15, 2002; 62(16): 4671 - 4677. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Dash, S. A. Mach, S. Blum, and A. N. Moore Intrahippocampal Wortmannin Infusion Enhances Long-Term Spatial and Contextual Memories Learn. Mem., July 1, 2002; 9(4): 167 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Karmakar, J. Piotrowski, R. M. Brosh Jr., J. A. Sommers, S. P. L. Miller, W.-H. Cheng, C. M. Snowden, D. A. Ramsden, and V. A. Bohr Werner Protein Is a Target of DNA-dependent Protein Kinase in Vivo and in Vitro, and Its Catalytic Activities Are Regulated by Phosphorylation J. Biol. Chem., May 17, 2002; 277(21): 18291 - 18302. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blancher, J. W. Moore, N. Robertson, and A. L. Harris Effects of ras and von Hippel-Lindau (VHL) Gene Mutations on Hypoxia-inducible Factor (HIF)-1{alpha}, HIF-2{alpha}, and Vascular Endothelial Growth Factor Expression and Their Regulation by the Phosphatidylinositol 3'-Kinase/Akt Signaling Pathway Cancer Res., October 1, 2001; 61(19): 7349 - 7355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tezuka, H. Watanabe, S. Nakamura, D. Yu, W. Aung, T. Sasaki, H. Shibuya, and M. Miura Antiapoptotic Activity Is Dispensable for Insulin-like Growth Factor I Receptor-mediated Clonogenic Radioresistance after {gamma}-Irradiation Clin. Cancer Res., October 1, 2001; 7(10): 3206 - 3214. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pospiech, A. K. Rytkonen, and J. E. Syvaoja The role of DNA polymerase activity in human non-homologous end joining Nucleic Acids Res., August 1, 2001; 29(15): 3277 - 3288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Gupta, V. J. Bakanauskas, G. J. Cerniglia, Y. Cheng, E. J. Bernhard, R. J. Muschel, and W. G. McKenna The Ras Radiation Resistance Pathway Cancer Res., May 1, 2001; 61(10): 4278 - 4282. [Abstract] [Full Text] |
||||
![]() |
I. Han, S. Harada, D. Weaver, Y. Xue, W. Lane, S. Orstavik, B. Skalhegg, and E. Kieff EBNA-LP Associates with Cellular Proteins Including DNA-PK and HA95 J. Virol., March 1, 2001; 75(5): 2475 - 2481. [Abstract] [Full Text] |
||||
![]() |
D. Kultz and D. Chakravarty Hyperosmolality in the form of elevated NaCl but not urea causes DNA damage in murine kidney cells PNAS, February 13, 2001; 98(4): 1999 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Danilkovitch, S. Donley, A. Skeel, and E. J. Leonard Two Independent Signaling Pathways Mediate the Antiapoptotic Action of Macrophage-Stimulating Protein on Epithelial Cells Mol. Cell. Biol., March 15, 2000; 20(6): 2218 - 2227. [Abstract] [Full Text] |
||||
![]() |
G. C. M. Smith, R. B. Cary, N. D. Lakin, B. C. Hann, S.-H. Teo, D. J. Chen, and S. P. Jackson Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM PNAS, September 28, 1999; 96(20): 11134 - 11139. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Frit, R.-Y. Li, D. Arzel, B. Salles, and P. Calsou Ku Entry into DNA Inhibits Inward DNA Transactions in Vitro J. Biol. Chem., November 10, 2000; 275(46): 35684 - 35691. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-P. Li, S. Periyasamy, T. J. Jones, and E. R. Sanchez Heat and Chemical Shock Potentiation of Glucocorticoid Receptor Transactivation Requires Heat Shock Factor (HSF) Activity. MODULATION OF HSF BY VANADATE AND WORTMANNIN J. Biol. Chem., August 18, 2000; 275(34): 26058 - 26065. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Geddis, N. E. Fox, and K. Kaushansky Phosphatidylinositol 3-Kinase Is Necessary but Not Sufficient for Thrombopoietin-induced Proliferation in Engineered Mpl-bearing Cell Lines as Well as in Primary Megakaryocytic Progenitors J. Biol. Chem., September 7, 2001; 276(37): 34473 - 34479. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |